Literature DB >> 23143657

Cross-regulation between cardiac muscarinic acetylcholine receptors and β-adrenoceptors: lessons for use of knock-out mice.

Stefan Dhein, Sandy von Salisch, Martin C Michel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23143657     DOI: 10.1007/s00210-012-0805-4

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  22 in total

1.  beta 1-and beta 2-adrenergic receptors exhibit differing susceptibility to muscarinic accentuated antagonism.

Authors:  O Aprigliano; V O Rybin; E Pak; R B Robinson; S F Steinberg
Journal:  Am J Physiol       Date:  1997-06

2.  Beta-blockade reduces effects of adenosine and carbachol by transregulation of inhibitory receptors and Gi proteins.

Authors:  M M Borst; R Marquetant; W Kübler; R H Strasser
Journal:  Am J Physiol       Date:  1997-04

Review 3.  Urinary bladder contraction and relaxation: physiology and pathophysiology.

Authors:  Karl-Erik Andersson; Anders Arner
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

4.  Mechanisms of supersensitivity to sympathomimetic amines in the chronically denervated heart of the conscious dog.

Authors:  D E Vatner; M Lavallee; J Amano; A Finizola; C J Homcy; S F Vatner
Journal:  Circ Res       Date:  1985-07       Impact factor: 17.367

5.  Neuronally released acetylcholine acts on the M2 muscarinic receptor to oppose the relaxant effect of isoproterenol on cholinergic contractions in mouse urinary bladder.

Authors:  Frederick J Ehlert; Simon Ahn; Kirk J Pak; Grace J Park; Marline S Sangnil; John A Tran; Minoru Matsui
Journal:  J Pharmacol Exp Ther       Date:  2007-05-01       Impact factor: 4.030

6.  Chronic beta-blockade transregulates inhibitory A1 adenosine and muscarinic M2 receptors of the adenylyl cyclase system.

Authors:  R Marquetant; B Brehm; R H Strasser
Journal:  J Mol Cell Cardiol       Date:  1992-05       Impact factor: 5.000

7.  Decrease in beta 1-adrenergic and M2-muscarinic receptor mRNA levels and unchanged accumulation of mRNAs coding for G alpha i-2 and G alpha s proteins in rat cardiac hypertrophy.

Authors:  A Mondry; F Bourgeois; F Carré; B Swynghedauw; J M Moalic
Journal:  J Mol Cell Cardiol       Date:  1995-10       Impact factor: 5.000

8.  Chronic beta 1-adrenoceptor antagonist treatment sensitizes beta 2-adrenoceptors, but desensitizes M2-muscarinic receptors in the human right atrium.

Authors:  S Motomura; N M Deighton; H R Zerkowski; N Doetsch; M C Michel; O E Brodde
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

9.  Chronic atropine administration diminishes the contribution of vasoactive intestinal polypeptide to heart rate regulation.

Authors:  J Kuncová; S Faitová; J Capouch; M Stengl; J Slavíková
Journal:  Physiol Res       Date:  2007-11-30       Impact factor: 1.881

10.  Chronic sympathectomy of canine cardiac ventricles affects Gs-adenylyl cyclase coupling and muscarinic receptor density.

Authors:  E E Quist; S C Lee; R Vasan; B Foresman; P Gwirtz; C E Jones
Journal:  J Cardiovasc Pharmacol       Date:  1994-06       Impact factor: 3.105

View more
  3 in total

1.  Do β-adrenoceptor agonists induce homologous or heterologous desensitization in rat urinary bladder?

Authors:  Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-10       Impact factor: 3.000

2.  Muscarinic receptor subtype mRNA expression in the human prostate: association with age, pathological diagnosis, prostate size, or potentially interfering medications?

Authors:  Lambertus P W Witte; Christine A Teitsma; Jean J M C H de la Rosette; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-06       Impact factor: 3.000

Review 3.  The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease.

Authors:  Philippa R Dale; Hana Cernecka; Martina Schmidt; Mark R Dowling; Steven J Charlton; Michael P Pieper; Martin C Michel
Journal:  Curr Opin Pharmacol       Date:  2014-03-27       Impact factor: 5.547

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.